The present invention relates to novel diarylacetylene hydrazide compounds of formula (I) or pharmaceutically acceptable salt thereof, as tyrosine kinase inhibitors, the process for their preparation, and to the use of the compounds of formula (I) in the preparation of pharmaceutical compositions for the therapeutic treatment of disorders related to tyrosine kinases, in warm-blooded animals
本发明涉及一种新颖的二芳基
乙炔基
腙化合物,其
化学式为(I),或其药学上可接受的盐,作为
酪氨酸激酶
抑制剂,其制备过程,以及将化合物(I)用于制备与温血动物的
酪氨酸激酶相关疾病的治疗药物组合物。